StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$14.55+0.63 (+4.53%)

Close on Nov 18, 2026Market cap $1.05BP/E –Yield –

Omeros net income

Net income is the profit left for shareholders after every expense, interest and tax.

Omeros's net income for the twelve months ending Jun 30, 2026 was $124.83M. For fiscal 2025 it was -$3.35M. The highest annual figure on record is $194.24M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.35M–
FY2024Dec 31, 2024-$156.82M–
FY2023Dec 31, 2023-$117.81M-348.5%
FY2022Dec 31, 2022$47.42M-75.6%
FY2021Dec 31, 2021$194.24M–
FY2020Dec 31, 2020-$138.06M–
FY2019Dec 31, 2019-$84.49M–
FY2018Dec 31, 2018-$126.76M–
FY2017Dec 31, 2017-$53.48M–
FY2016Dec 31, 2016-$66.75M–
FY2015Dec 31, 2015-$75.10M–
FY2014Dec 31, 2014-$73.67M–
FY2013Dec 31, 2013-$39.80M–
FY2012Dec 31, 2012-$38.44M–
FY2011Dec 31, 2011-$28.55M–
FY2010Dec 31, 2010-$29.25M–
FY2009Dec 31, 2009-$21.09M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$13.23M–
Q1 FY2026Mar 31, 2026$56.06M–
Q4 FY2025Dec 31, 2025$86.45M–
Q3 FY2025Sep 30, 2025-$30.92M–
Q2 FY2025Jun 30, 2025-$25.42M–
Q1 FY2025Mar 31, 2025-$33.46M–
Q4 FY2024Dec 31, 2024-$31.36M–
Q3 FY2024Sep 30, 2024-$32.23M–
Q2 FY2024Jun 30, 2024-$56.04M–
Q1 FY2024Mar 31, 2024-$37.18M–
Q4 FY2023Dec 31, 2023-$9.07M-107.0%
Q3 FY2023Sep 30, 2023-$37.75M–
Q2 FY2023Jun 30, 2023-$37.29M–
Q1 FY2023Mar 31, 2023-$33.70M–
Q4 FY2022Dec 31, 2022$128.73M-54.1%
Q3 FY2022Sep 30, 2022-$17.46M–
Q2 FY2022Jun 30, 2022-$30.85M–
Q1 FY2022Mar 31, 2022-$33.01M–
Q4 FY2021Dec 31, 2021$280.62M–
Q1 FY2021Mar 31, 2021-$35.09M–
Q4 FY2020Dec 31, 2020-$37.27M–
Q3 FY2020Sep 30, 2020-$38.46M–
Q2 FY2020Jun 30, 2020-$33.29M–
Q1 FY2020Mar 31, 2020-$29.03M–
Q4 FY2019Dec 31, 2019-$29.23M–
Q3 FY2019Sep 30, 2019-$16.46M–
Q2 FY2019Jun 30, 2019-$14.45M–
Q1 FY2019Mar 31, 2019-$24.35M–
Q4 FY2018Dec 31, 2018-$23.53M–
Q3 FY2018Sep 30, 2018-$39.47M–
Q2 FY2018Jun 30, 2018-$33.70M–
Q1 FY2018Mar 31, 2018-$30.05M–
Q4 FY2017Dec 31, 2017-$16.55M–
Q3 FY2017Sep 30, 2017-$7.48M–
Q2 FY2017Jun 30, 2017-$14.36M–
Q1 FY2017Mar 31, 2017-$15.09M–
Q4 FY2016Dec 31, 2016-$19.63M–
Q3 FY2016Sep 30, 2016-$13.96M–
Q2 FY2016Jun 30, 2016-$12.61M–

More Omeros figures

See a number that looks wrong?